Clinical Publications 2021
 
  1. Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohorts. Sherman BT, Hu X, Singh K, Haine L, Rupert AW, Neaton JD, Lundgren JD, Imamichi T, Chang W, Lane HC; ESPRIT, SMART and START Study Groups.
    AIDS. 2021;35(2):193-204. Abstract
     
  2. How are rapid diagnostic tests for infectious diseases used in clinical practice: a global survey by the International Society of Antimicrobial Chemotherapy (ISAC). Poole S, Townsend J, Wertheim H, Kidd SP, Welte T, Schuetz P, Luyt CE, Beishuizen A, Jensen JS, Del Castillo JG, Plebani M, Saeed K.
    Eur J Clin Microbiol Infect Dis. 2021;40(2):429-434. Abstract
     
  3. Identification of two different coagulation phenotypes in people living with HIV with undetectable viral replication. Fink A, Knudsen AD, Thudium RF, Von Stemann JH, Afzal S, Lundgren J, Kirkegaard-Klitbo DM, Ostrowski SR, Nordestgaard BG, Nielsen SD.
    Sci Rep. 2021;11(1):4383. Abstract
     
  4. Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents. Byonanebye DM; RESPOND Study Group.
    AIDS. 2021.Epub ahead of print. Abstract
     
  5. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients. Rezahosseini O, Ekenberg C, Møller DL, Sørensen SS, Wareham NE, Perch M, Gustafsson F, Rasmussen A, Kirkby N, Reekie J, Lundgren J, Nielsen SD.
    J Infect Dis. 2021:jiab024. Abstract
     
  6. Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory. Podlekareva DN, Folkvardsen DB, Skrahina A, Vassilenko A, Skrahin A, Hurevich H, Klimuk D, Karpov I, Lundgren JD, Kirk O, Lillebaek T.
    Tuberc Res Treat. 2021;2021:6646239. Abstract
     
  7. Causes and outcomes of hospitalizations among people living with HIV in Georgia's referral institution, 2012-2017. Rukhadze N, Kirk O, Chkhartishvili N, Bolokadze N, Sharvadze L, Gabunia P, Lundgren J, Tsertsvadze T.
    Int J STD AIDS. 2021:956462420984701. Abstract
     
  8. Prevalence and Outcomes for Heavily Treatment-Experienced (HTE) Individuals Living with Human Immunodeficiency Virus in a European Cohort. Pelchen-Matthews A, Borges ÁH, Reekie J, Rasmussen LD, Wiese L, Weber J, Pradier C, Degen O, Paredes R, Tau L, Flamholc L, Gottfredsson M, Kowalska J, Jablonowska E, Mozer-Lisewska I, Radoi R, Vasylyev M, Kuznetsova A, Begovac J, Svedhem V, Clark A, Cozzi-Lepri A; EuroSIDA study
    J Acquir Immune Defic Syndr. 2021. Epub ahead of print. Abstract
     
  9. Hematological toxicity in patients with solid malignant tumors treated with radiation - Temporal analysis, dose response and impact on survival. Terrones-Campos C, Ledergerber B, Vogelius IR, Helleberg M, Specht L, Lundgren J.
    Radiother Oncol. 2021;158:175-183. Abstract
     
  10. Pulmonary Arterial Enlargement in Well-Treated Persons With Human Immunodeficiency Virus. Knudsen AD, Ronit A, Kristensen T, Thomsen MT, Lebech AM, Cuong MH, Sigvardsen PE, Kühl JT, Fuchs A, Køber L, Lundgren J, Vestbo J, Kofoed KF, Nielsen SD.
    J Infect Dis. 2021;223(1):94-100. Abstract
     
  11. The association of human leukocyte antigen alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies. Ekenberg C, Reekie J, Zucco AG, Murray DD, Sharma S, Macpherson CR, Babiker A, Kan V, Lane HC, Neaton JD, Lundgren JD; INSIGHT START, SMART Study Groups.
    AIDS. 2021;35(5):783-789. Abstract
     
  12. Collaborative tuberculosis/HIV activities in the European Region. de Vries G, van de Berg S, van Dam A, Hasanova S, Pareek M, van der Werf MJ, Podlekareva DN.
    ERJ Open Res. 2021;7(1):00721-2020. Abstract
     
  13. Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States. Boettiger DC, Newall AT, Phillips A, Bendavid E, Law MG, Ryom L, Reiss P, Mocroft A, Bonnet F, Weber R, El-Sadr W, d'Arminio Monforte A, de Wit S, Pradier C, Hatleberg CI, Lundgren J, Sabin C, Kahn JG, Kazi DS.
    J Int AIDS Soc. 2021;24(3):e25690. Abstract
     
  14. Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study. Baxter JD, Dunn D, Tostevin A, Marvig RL, Bennedbaek M, Cozzi-Lepri A, Sharma S, Kozal MJ, Gompels M, Pinto AN, Lundgren J; INSIGHT START Study Group.
    HIV Med. 2021;22(5):360-371. Abstract
     
  15. ABO blood types and sepsis mortality. Itenov TS, Sessler DI, Khanna AK, Ostrowski SR, Johansson PI, Erikstrup C, Pedersen OB, Rygård SL, Holst LB, Bestle MH, Hein L, Lindhardt A, Tousi H, Andersen MH, Mohr T, Lundgren JD, Jensen JU.
    Ann Intensive Care. 2021;11(1):61. Abstract
     
  16. Human immunotypes impose selection on viral genotypes through viral epitope specificity. Gabrielaite M, Bennedbæk M, Zucco AG, Ekenberg C, Murray DD, Kan VL, Touloumi G, Vandekerckhove L, Turner D, Neaton J, Lane HC, Safo S, Arenas-Pinto A, Polizzotto MN, Günthard HF, Lundgren JD, Marvig RL; INSIGHT START trial group.
    J Infect Dis. 2021:jiab253. Epub ahead of print. Abstract
     

​IN PRESS

  1. Prevalence and outcomes of pregnancies in women living with HIV over a 20-year period: The EuroSIDA study, 1996 to 2015. Pelchen-Matthews A, et al.
    AIDS 2021